Trial Profile
A Randomized, Double-blind, Multi-center, Active-controlled, Parallel-designed, Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Korean Healthy Children Aged 12~23 Months
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2023
Price :
$35
*
At a glance
- Drugs BR-8003 (Primary) ; Hepatitis A vaccine inactivated
- Indications Hepatitis A
- Focus Pharmacodynamics; Registrational
- Acronyms VITHA-C
- Sponsors Boryung Pharmaceutical
- 04 Jul 2023 Status changed from active, no longer recruiting to completed.
- 07 Sep 2018 New trial record